Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q2 2024 Earnings Call Transcript

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q2 2024 Earnings Call Transcript August 1, 2024

Apellis Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.28, expectations were $-0.33.

Operator: Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Apellis Pharmaceuticals Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer...